Ketamine has been the subject of research in recent years, highlighting its potential to treat and cure depression. The U.S. Food and Drug Administration (FDA) authorized Kernel, a neurotech company ...

Bryan Johnson founded Kernel to offer neurodata acquisition and analytics services at an affordable price. Bryan Johnson says his “secret weapon” when it came to launching neurotech company Kernel was ...

CYBN partners with pioneer company focused on exploring, quantifying the human mind Innovative Flow technology adds exciting dimension to Cybin's commitment to develop breakthrough treatments for ...